MC1960A1 - Derives d'acide hydrocinnamique - Google Patents

Derives d'acide hydrocinnamique

Info

Publication number
MC1960A1
MC1960A1 MC881992A MC1992A MC1960A1 MC 1960 A1 MC1960 A1 MC 1960A1 MC 881992 A MC881992 A MC 881992A MC 1992 A MC1992 A MC 1992A MC 1960 A1 MC1960 A1 MC 1960A1
Authority
MC
Monaco
Prior art keywords
acid derivatives
hydrocinnamic acid
hydrocinnamic
derivatives
acid
Prior art date
Application number
MC881992A
Other languages
English (en)
French (fr)
Inventor
Aschwanden Werner
Imhof Rene
Jakob-Roetne Roland
Kyburz Emilio
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1960A1 publication Critical patent/MC1960A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/31—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC881992A 1987-07-21 1988-07-18 Derives d'acide hydrocinnamique MC1960A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH276487 1987-07-21

Publications (1)

Publication Number Publication Date
MC1960A1 true MC1960A1 (fr) 1989-06-30

Family

ID=4241087

Family Applications (1)

Application Number Title Priority Date Filing Date
MC881992A MC1960A1 (fr) 1987-07-21 1988-07-18 Derives d'acide hydrocinnamique

Country Status (25)

Country Link
US (2) US4883815A (ja)
EP (1) EP0300371A1 (ja)
JP (1) JPS6447748A (ja)
KR (1) KR890001954A (ja)
CN (1) CN1015622B (ja)
AU (1) AU603470B2 (ja)
DD (1) DD277071A5 (ja)
DK (1) DK405888A (ja)
FI (1) FI883441A (ja)
GB (1) GB2207135B (ja)
HU (1) HU198676B (ja)
IL (1) IL87130A0 (ja)
IN (1) IN167395B (ja)
IS (1) IS3376A7 (ja)
MC (1) MC1960A1 (ja)
MT (1) MTP1023B (ja)
MW (1) MW2688A1 (ja)
NO (1) NO883233L (ja)
NZ (1) NZ225442A (ja)
OA (1) OA08746A (ja)
PT (1) PT88041A (ja)
TN (1) TNSN88076A1 (ja)
YU (2) YU141488A (ja)
ZA (1) ZA885102B (ja)
ZW (1) ZW9288A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250539A (en) * 1991-08-21 1993-10-05 Eli Lilly And Company Hexahydrobenzo[f]quinolinones
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
ES2125884T3 (es) * 1991-08-21 1999-03-16 Lilly Co Eli Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa.
US5574054A (en) * 1992-05-12 1996-11-12 Zeria Pharmaceutical Co., Ltd. Quaternary ammonium salts and use thereof as medicine
US5849914A (en) * 1996-08-09 1998-12-15 Merck & Co., Inc. Compounds formed by an asymmetric conjugate addition reaction
US6172235B1 (en) 1996-08-09 2001-01-09 Merck & Co., Inc. Asymmetric conjugate addition reaction
CA2262837C (en) * 1996-08-09 2003-03-11 Richard D. Tillyer An asymmetric conjugate addition reaction
GB9920872D0 (en) 1999-09-04 1999-11-10 Glaxo Group Ltd Benzophenones as inhibitors of reverse transcriptase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3795683A (en) * 1970-08-19 1974-03-05 Hoffmann La Roche 2,3,4,5-tetrahydro-1h-3-benzazepines
JPS6033439B2 (ja) * 1980-03-07 1985-08-02 財団法人相模中央化学研究所 ジペプチドの製造方法
IT1175926B (it) * 1984-01-13 1987-08-12 Debi Derivati Biologici Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina
DE3773950D1 (de) * 1986-01-23 1991-11-28 Hoffmann La Roche Benzazecin-derivate.

Also Published As

Publication number Publication date
IN167395B (ja) 1990-10-20
KR890001954A (ko) 1989-04-06
CN1036952A (zh) 1989-11-08
OA08746A (fr) 1989-03-31
DK405888D0 (da) 1988-07-20
US5017608A (en) 1991-05-21
MTP1023B (en) 1989-07-18
YU141488A (en) 1990-06-30
HU198676B (en) 1989-11-28
JPS6447748A (en) 1989-02-22
NO883233D0 (no) 1988-07-20
TNSN88076A1 (fr) 1990-07-10
FI883441A0 (fi) 1988-07-20
DK405888A (da) 1989-01-22
NZ225442A (en) 1991-05-28
EP0300371A1 (de) 1989-01-25
ZA885102B (en) 1989-03-29
GB2207135A (en) 1989-01-25
YU39890A (en) 1991-10-31
GB8817291D0 (en) 1988-08-24
GB2207135B (en) 1991-05-15
MW2688A1 (en) 1989-04-12
FI883441A (fi) 1989-01-22
US4883815A (en) 1989-11-28
AU603470B2 (en) 1990-11-15
IS3376A7 (is) 1989-01-22
NO883233L (no) 1989-01-23
AU1917688A (en) 1989-01-27
HUT47077A (en) 1989-01-30
ZW9288A1 (en) 1989-02-01
DD277071A5 (de) 1990-03-21
IL87130A0 (en) 1988-12-30
CN1015622B (zh) 1992-02-26
PT88041A (pt) 1989-06-30

Similar Documents

Publication Publication Date Title
MC1881A1 (fr) Derives de l'acide phosphinique
MC2106A1 (fr) Derives d'aminoacides
DK340088D0 (da) Aminosyrederivater
DK406686D0 (da) Carboxylsyrederivater
MA20648A1 (fr) Tensioactifs derives de l'acide citrique
MC2103A1 (fr) Derives d'aminoacides
DE122005000012I2 (de) N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl-Glutamins{urederivate
DK686487D0 (da) 1h-imidazol-5-carboxylsyrederivater
MC1512A1 (fr) Nouveaux derives d'acide phenoxyalkylcarboxylique
DK523288D0 (da) Aminosyrederivater
DK101287A (da) 1h-imidazol-5-carboxylsyrederivater
MC1960A1 (fr) Derives d'acide hydrocinnamique
DK655487A (da) Furanuronsyrederivater
BE864321A (fr) Derives d'acide oxazolinoazetidinylbutyrique
DK702688D0 (da) Epipodophyllotoxin-glucosid 4'-acylderivater
DK482488D0 (da) 3'-demethoxyepipodophyllotoxinglucosidderivater
MA23133A1 (fr) Derives d'acide d'acyloxyhexanoique .
DK670589D0 (da) Carboxylsyrederivater
MA22543A1 (fr) Derives de l'acide propenoique
DE59002430D1 (de) Cyclopropanoylaminosäureamid-Derivate.
DK9588A (da) 2,1-benzothiazepin-2,2-dioxid-5-carboxylsyrederivater
FR2581645B1 (fr) Derives de l'acide octenoique
FR2556346B1 (fr) Derives de l'acide malonyloxacepheme-carboxylique
FR2603282B1 (fr) Derives d'isoquinoleine
MC1816A1 (fr) Derives d'isoquinoleine

Legal Events

Date Code Title Description
YP Annual fee paid